Table 7.
Increased incidence of comorbid disorders associated with the use of soy-based infant formula.
| Soy |
Non-soy |
|||||
|---|---|---|---|---|---|---|
| N | % | N | % | Pa,c | CIb | |
| Females | ||||||
| Allergies | 44 | 6.8 | 217 | 1.8 | 0.1 | 0.7–22 |
| ADHD | 44 | 6.8 | 217 | 2.8 | 0.2 | 0.5–12 |
| Asthma | 44 | 4.5 | 217 | 9.2 | 0.5 | 0.1–2.2 |
| Bipolar | 42 | 14.3 | 217 | 15.7 | 1.0 | 0.3–2.5 |
| Males | ||||||
| Allergies | 297 | 3.0 | 1,391 | 1.4 | 0.06 | 0.9–5.0 |
| ADHD | 297 | 6.7 | 1,391 | 4.0 | 0.04 | 1.0–3.0 |
| Asthma | 297 | 8.4 | 1,391 | 4.9 | 0.02 | 1.1–2.9 |
| Bipolar | 273 | 23.8 | 1,390 | 15.2 | 0 | 1.3–2.4 |
| Genders combined | ||||||
| Allergies | 341 | 3.5 | 1,608 | 1.5 | 0.01 | 1.1–5.2 |
| ADHD | 341 | 6.7 | 1,608 | 3.9 | 0.04 | 1.0–3.0 |
| Asthma | 341 | 7.9 | 1,608 | 5.5 | 0.08 | 0.9–2.4 |
| Bipolar | 315 | 22.5 | 1,607 | 15.2 | 0.001 | 1.2–2.2 |
aFisher’s exact test.
b95% confidence intervals.
cChi-squared analysis.